# Mitralign Percutaneous Annuloplasty First in Man Study

> **NCT01852149** · NA · COMPLETED · sponsor: **Mitralign, Inc.** · enrollment: 35 (actual)

## Conditions studied

- Functional Mitral Regurgitation

## Interventions

- **DEVICE:** MPAS Implant

## Key facts

- **NCT ID:** NCT01852149
- **Lead sponsor:** Mitralign, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2014-03
- **Final completion:** 2015-09
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2016-03-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01852149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01852149, "Mitralign Percutaneous Annuloplasty First in Man Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01852149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*